|
TAF13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.4252000125079E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.03579997304359E-09 |
| Normal-vs-Stage2 |
3.92270000000305E-05 |
| Normal-vs-Stage3 |
2.479700E-02 |
| Normal-vs-Stage4 |
4.0503000000025E-05 |
| Stage1-vs-Stage2 |
8.099800E-01 |
| Stage1-vs-Stage3 |
1.316360E-01 |
| Stage1-vs-Stage4 |
7.360400E-01 |
| Stage2-vs-Stage3 |
3.277200E-01 |
| Stage2-vs-Stage4 |
5.618200E-01 |
| Stage3-vs-Stage4 |
2.610600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.15160000927028E-09 |
| Normal-vs-AfricanAmerican |
2.90010000003615E-06 |
| Normal-vs-Asian |
8.494400E-01 |
| Caucasian-vs-AfricanAmerican |
7.212000E-01 |
| Caucasian-vs-Asian |
4.857000E-01 |
| AfricanAmerican-vs-Asian |
5.196200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.42330053193507E-10 |
| Normal-vs-Female |
3.602400E-04 |
| Male-vs-Female |
2.904200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.54499999996494E-06 |
| Normal-vs-Extreme_Weight |
9.70109548248388E-11 |
| Normal-vs-Obese |
2.02999999998621E-06 |
| Normal-vs-Extreme_Obese |
2.019600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.495000E-01 |
| Normal_Weight-vs-Obese |
4.490000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.400800E-01 |
| Extreme_Weight-vs-Obese |
1.166760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.102400E-01 |
| Obese-vs-Extreme_Obese |
5.232200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.480200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.73699996000687E-09 |
| Normal-vs-Age(61-80Yrs) |
3.11259999996594E-08 |
| Normal-vs-Age(81-100Yrs) |
2.584700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.888400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.831200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.545600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.033400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.547800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.463400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.47110168070253E-11 |
| Normal-VS-Type2 PRCC |
2.897200E-03 |
| Normal-VS-KIRP CIMP |
2.939800E-02 |
| Normal-VS-Unclassified PRCC |
8.19860000000894E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.947700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.302820E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.327400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.548600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.579820E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.623800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.09439999998562E-06 |
| Normal-vs-N1 |
4.141300E-03 |
| Normal-vs-N2 |
1.465370E-01 |
| N0-vs-N1 |
4.073400E-01 |
| N0-vs-N2 |
6.713400E-01 |
| N1-vs-N2 |
4.111400E-01 |
|
|
